Identification of the first homozygous intragenic deletion in the YY1AP1 gene in a consanguineous family: New insights into the phenotypic variability associated with Grange syndrome.

CNV-exome Grange syndrome YY1AP1 fibromuscular dysplasia

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
Nov 2023
Historique:
revised: 17 08 2023
received: 09 03 2023
accepted: 23 08 2023
pubmed: 12 9 2023
medline: 12 9 2023
entrez: 12 9 2023
Statut: ppublish

Résumé

Grange syndrome (GRNG-MIM#135580) is a rare recessive disorder associating variable features including diffuse vascular stenosis, brachysyndactyly, osteopenia with increased bone fragility, cardiac malformations, and variable developmental delay. Since its first description in 1998, only 15 individuals from 10 families have been reported, carrying homozygous or compound heterozygous frameshift or nonsense variants in YY1AP1. In a patient with cutaneous and bone syndactyly and a hemorrhagic stroke at the age of 16 months, consistent with a clinical diagnosis of GRNG, we performed exome sequencing after negative array-CGH and congenital limb malformation panel results. Copy number variant analysis from exome data identified a homozygous intragenic out-of-frame deletion of 1.84 kb encompassing exons seven and eight of YY1AP1, confirming a molecular diagnosis of GRNG. Genetic counseling led to the identification of additional family members compatible with GRNG. Here, we provide new insights into the phenotypic variability associated with GRNG and highlight the utility of the detection of small copy number variants to identify the molecular causes of heterogeneous malformative genetic disorders.

Identifiants

pubmed: 37698238
doi: 10.1002/ajmg.a.63394
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2728-2735

Subventions

Organisme : Dijon University Hospital
Organisme : the ISITE-BFC (PIA ANR)
Organisme : the European Union
Organisme : the French Ministry of Health
ID : 2016-A00350-51

Informations de copyright

© 2023 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Baux, D., Van Goethem, C., Ardouin, O., Guignard, T., Bergougnoux, A., Koenig, M., & Roux, A.-F. (2021). MobiDetails: Online DNA variants interpretation. European Journal of Human Genetics, 29(2), 356-360. https://doi.org/10.1038/s41431-020-00755-z
Berra, E., Dominiczak, A. F., Touyz, R. M., Pierard, S., Hammer, F., Rossi, G. P., Micali, R. G., Staessen, J. A., Bursztyn, M., Kahan, T., & Persu, A. (2018). Management of a pregnant woman with fibromuscular dysplasia. Hypertension (Dallas, Texas: 1979), 71(4), 540-547. https://doi.org/10.1161/HYPERTENSIONAHA.118.10819
Ciuffetelli Alamo, I. V., Kwartler, C. S., Regalado, E. R., Afifi, R. O., Parkash, S., Rideout, A., Guo, D., & Milewicz, D. M. (2019). Grange syndrome due to homozygous YY1AP1 missense rare variants. American Journal of Medical Genetics Part A, 179(12), 2500-2505. https://doi.org/10.1002/ajmg.a.61379
Fromer, M., Moran, J. L., Chambert, K., Banks, E., Bergen, S. E., Ruderfer, D. M., Handsaker, R. E., McCarroll, S. A., O'Donovan, M. C., Owen, M. J., Kirov, G., Sullivan, P. F., Hultman, C. M., Sklar, P., & Purcell, S. M. (2012). Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. American Journal of Human Genetics, 91(4), 597-607. https://doi.org/10.1016/j.ajhg.2012.08.005
Gornik, H. L., Persu, A., Adlam, D., Aparicio, L. S., Azizi, M., Boulanger, M., Bruno, R. M., de Leeuw, P., Fendrikova-Mahlay, N., Froehlich, J., Ganesh, S. K., Gray, B. H., Jamison, C., Januszewicz, A., Jeunemaitre, X., Kadian-Dodov, D., Kim, E. S., Kovacic, J. C., Mace, P., … Plouin, P.-F. (2019). First international consensus on the diagnosis and management of fibromuscular dysplasia. Vascular Medicine (London, England), 24(2), 164-189. https://doi.org/10.1177/1358863X18821816
Grange, D. K., Balfour, I. C., Chen, S. C., & Wood, E. G. (1998). Familial syndrome of progressive arterial occlusive disease consistent with fibromuscular dysplasia, hypertension, congenital cardiac defects, bone fragility, brachysyndactyly, and learning disabilities. American Journal of Medical Genetics, 75(5), 469-480. https://doi.org/10.1002/(sici)1096-8628(19980217)75:5<469::aid-ajmg4>3.0.co;2-i
Guo, D., Duan, X.-Y., Regalado, E. S., Mellor-Crummey, L., Kwartler, C. S., Kim, D., Lieberman, K., de Vries, B. B. A., Pfundt, R., Schinzel, A., Kotzot, D., Shen, X., Yang, M.-L., Bamshad, M. J., Nickerson, D. A., Gornik, H. L., Ganesh, S. K., Braverman, A. C., Grange, D. K., & Milewicz, D. M. (2017). Loss-of-function mutations in YY1AP1 lead to Grange syndrome and a fibromuscular dysplasia-like vascular disease. The American Journal of Human Genetics, 100(1), 21-30. https://doi.org/10.1016/j.ajhg.2016.11.008
Karakaya, T., Turkyilmaz, A., Eris, D., Kaya, M., Oksuz, K., Eryigit, M. A., & Gönen, G. (2023). The new youngest case of Grange syndrome with a novel biallelic pathogenic variant in YY1AP1. Molecular Syndromology, 14(3), 239-245. https://doi.org/10.1159/000527785
Nambot, S., Thevenon, J., Kuentz, P., Duffourd, Y., Tisserant, E., Bruel, A.-L., Mosca-Boidron, A.-L., Masurel-Paulet, A., Lehalle, D., Jean-Marçais, N., Lefebvre, M., Vabres, P., El Chehadeh-Djebbar, S., Philippe, C., Tran Mau-Them, F., St-Onge, J., Jouan, T., Chevarin, M., Poé, C., … Orphanomix Physicians’ Group. (2018). Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: Substantial interest of prospective annual reanalysis. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 20(6), 645-654. https://doi.org/10.1038/gim.2017.162
Pappaccogli, M., Prejbisz, A., Ciurică, S., Bruno, R. M., Aniszczuk-Hybiak, A., Bracalente, I., De Backer, T., Debiève, F., Delmotte, P., Di Monaco, S., Jarraya, F., Gordin, D., Kosiński, P., Kroon, A. A., Maas, A. H. E. M., Marcon, D., Minuz, P., Montagud-Marrahi, E., Pasquet, A., … the Working Group “Hypertension and the Kidney” of the ESH. (2020). Pregnancy-related complications in patients with fibromuscular dysplasia. Hypertension, 76(2), 545-553. https://doi.org/10.1161/HYPERTENSIONAHA.120.15349
Raggio, V., Dell'Oca, N., Simoes, C., Tapié, A., Medici, C., Costa, G., Rodriguez, S., Greif, G., Garrone, E., Rovella, M. L., Gonzalez, V., Halty, M., González, G., Shin, J.-Y., Shin, S.-Y., Kim, C., Seo, J.-S., Graña, M., Naya, H., & Spangenberg, L. (2021). Whole genome sequencing reveals a frameshift mutation and a large deletion in YY1AP1 in a girl with a panvascular artery disease. Human Genomics, 15, 28. https://doi.org/10.1186/s40246-021-00328-1
Rath, M., Spiegler, S., Strom, T. M., Trenkler, J., Kroisel, P. M., & Felbor, U. (2019). Identification of pathogenic YY1AP1 splice variants in siblings with Grange syndrome by whole exome sequencing. American Journal of Medical Genetics. Part A, 179(2), 295-299. https://doi.org/10.1002/ajmg.a.60700
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., & Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405-424. https://doi.org/10.1038/gim.2015.30
Saida, K., Kim, C., Ceroni, J., Bertola, D., Honjo, R., Mitsuhashi, S., Takata, A., Mizuguchi, T., Miyatake, S., Miyake, N., & Matsumoto, N. (2019). Hemorrhagic stroke and renovascular hypertension with Grange syndrome arising from a novel pathogenic variant in YY1AP1. Journal of Human Genetics, 64, 885-890. https://doi.org/10.1038/s10038-019-0626-0
Thevenon, J., Duffourd, Y., Masurel-Paulet, A., Lefebvre, M., Feillet, F., El Chehadeh-Djebbar, S., St-Onge, J., Steinmetz, A., Huet, F., Chouchane, M., Darmency-Stamboul, V., Callier, P., Thauvin-Robinet, C., Faivre, L., & Rivière, J. B. (2016). Diagnostic odyssey in severe neurodevelopmental disorders: Toward clinical whole-exome sequencing as a first-line diagnostic test. Clinical Genetics, 89(6), 700-707. https://doi.org/10.1111/cge.12732
Tisserant, E., Vitobello, A., Callegarin, D., Verdez, S., Bruel, A.-L., Aho Glele, L. S., Sorlin, A., Viora-Dupont, E., Konyukh, M., Marle, N., Nambot, S., Moutton, S., Racine, C., Garde, A., Delanne, J., Tran-Mau-Them, F., Philippe, C., Kuentz, P., Poulleau, M., … Callier, P. (2022). Copy number variants calling from WES data through eXome hidden Markov model (XHMM) identifies additional 2.5% pathogenic genomic imbalances smaller than 30 kb undetected by array-CGH. Annals of Human Genetics, 86(4), 171-180. https://doi.org/10.1111/ahg.12459
Volonghi, I., Frigerio, M., Mardighian, D., Gasparotti, R., Del Zotto, E., Giossi, A., Costa, P., Poli, L., Jeannin, G., Gregorini, G. A., Padovani, A., & Pezzini, A. (2012). Grange syndrome: An identifiable cause of stroke in young adults. American Journal of Medical Genetics Part A, 158A(11), 2894-2898. https://doi.org/10.1002/ajmg.a.35593
Wallerstein, R., Augustyn, A. M., Wallerstein, D., Elton, L., Tejeiro, B., Johnson, V., & Lieberman, K. (2006). A new case of Grange syndrome without cardiac findings. American Journal of Medical Genetics Part A, 140A(12), 1316-1320. https://doi.org/10.1002/ajmg.a.31125
Wang, C.-Y., Liang, Y.-J., Lin, Y.-S., Shih, H.-M., Jou, Y.-S., & Yu, W. C. Y. (2004). YY1AP, a novel co-activator of YY1. The Journal of Biological Chemistry, 279(17), 17750-17755. https://doi.org/10.1074/jbc.M310532200
Weymann, S., Yonekawa, Y., Khan, N., Martin, E., Heppner, F. L., Schinzel, A., & Kotzot, D. (2001). Severe arterial occlusive disorder and brachysyndactyly in a boy: A further case of Grange syndrome? American Journal of Medical Genetics, 99(3), 190-195.

Auteurs

E Viora-Dupont (E)

Genetics Department and Reference Center for Developmental Disorders and Malformative Syndromes for East France, Dijon Bourgogne University Hospital, Dijon, France.
UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.

A Denommé-Pichon (A)

UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.
Unité Fonctionnelle d'Innovation diagnostique des maladies rares, Dijon Bourgogne University Hospital, Dijon, France.

M Chevarin (M)

UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.
Unité Fonctionnelle d'Innovation diagnostique des maladies rares, Dijon Bourgogne University Hospital, Dijon, France.

O Patat (O)

Service de Génétique Médicale, CHU Toulouse, France, Toulouse, France.

M Willems (M)

Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Université de Montpellier, CHU de Montpellier, CLAD ASOOR Montpellier, Montpellier, France.
Institute for Neurosciences of Montpellier, Université de Montpellier, INSERM, Montpellier, France.

N Bourgon (N)

UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.

A Bruel (A)

UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.
Unité Fonctionnelle d'Innovation diagnostique des maladies rares, Dijon Bourgogne University Hospital, Dijon, France.

M Aubert-Mucca (M)

Service de Génétique Médicale, CHU Toulouse, France, Toulouse, France.

M Galinier (M)

Fédération des Services de Cardiologie, CHU Toulouse-Rangueil, Toulouse, France.
UMR UT3 CNRS 5288 Evolutionary Medicine, Obesity and Heart Failure: Molecular and Clinical Investigations, INI-CRCT F-CRIN, GREAT Networks, Toulouse, France.
Université Paul Sabatier-Toulouse III, Faculté de Médecine, Toulouse, France.

R Itier (R)

UMR UT3 CNRS 5288 Evolutionary Medicine, Obesity and Heart Failure: Molecular and Clinical Investigations, INI-CRCT F-CRIN, GREAT Networks, Toulouse, France.

S Decramer (S)

Centre Hospitalier Universitaire de Toulouse, Service de Nephrologie Pediatrique, Hopital des Enfants, Centre De Reference des Maladies Rénales Rares du Sud-Ouest, Toulouse, France.

A Piton (A)

Unité de Génétique Moléculaire, Strasbourg University Hospital, Strasbourg, France.

B Gerard (B)

Laboratoire de Diagnostic Génétique, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

C Billon (C)

Centre de Référence des Maladies Vasculaires Rares et Département de génétique, Hôpital Européen Georges Pompidou, Paris, France.

X Jeunemaitre (X)

Centre de Référence des Maladies Vasculaires Rares et Département de génétique, Hôpital Européen Georges Pompidou, Paris, France.

Y Duffourd (Y)

UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.
Unité Fonctionnelle d'Innovation diagnostique des maladies rares, Dijon Bourgogne University Hospital, Dijon, France.

P Callier (P)

UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.

C Thauvin (C)

UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.
Unité Fonctionnelle d'Innovation diagnostique des maladies rares, Dijon Bourgogne University Hospital, Dijon, France.
Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital d'Enfants, Dijon, France.

C Philippe (C)

UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.
Unité Fonctionnelle d'Innovation diagnostique des maladies rares, Dijon Bourgogne University Hospital, Dijon, France.

L Faivre (L)

Genetics Department and Reference Center for Developmental Disorders and Malformative Syndromes for East France, Dijon Bourgogne University Hospital, Dijon, France.
UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.

J Albuisson (J)

Centre de Référence des Maladies Vasculaires Rares et Département de génétique, Hôpital Européen Georges Pompidou, Paris, France.

A Vitobello (A)

UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.
Unité Fonctionnelle d'Innovation diagnostique des maladies rares, Dijon Bourgogne University Hospital, Dijon, France.

Classifications MeSH